{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-23-000035","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.106742+00:00","generated_at":"2026-06-19T01:37:10.757375+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Rad discloses Sartorius AG 2022 financials: sales €4.17B, net profit €913M","bullets":["Sartorius AG reported 2022 sales revenue of €4,174.7M and gross profit of €2,196.5M.","EBIT of €1,064.8M and net profit of €913.1M for the year ended December 31, 2022.","Cash flow from operations €734.2M; investing activities used €1,129.9M.","Total equity at year-end €2,658.9M; current assets €2,023.2M, current liabilities €1,803.4M.","Data sourced from Sartorius's IFRS consolidated financial statements publicly disclosed on Feb 17, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-23-000035","json":"https://secwatch.observer/filing/0000012208-23-000035.json","markdown":"https://secwatch.observer/filing/0000012208-23-000035.md","text":"https://secwatch.observer/filing/0000012208-23-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/0000012208-23-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/bio-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T01:37:10.757375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}